Oxaliplatin en es it fr

Oxaliplatin Brand names, Oxaliplatin Analogs

Oxaliplatin Brand Names Mixture

  • No information avaliable

Oxaliplatin Chemical_Formula

C8H12N2O4Pt

Oxaliplatin RX_link

http://www.rxlist.com/cgi/generic/eloxatin.htm

Oxaliplatin fda sheet

Oxaliplatin FDA

Oxaliplatin msds (material safety sheet)

Oxaliplatin MSDS

Oxaliplatin Synthesis Reference

No information avaliable

Oxaliplatin Molecular Weight

395.27 g/mol

Oxaliplatin Melting Point

No information avaliable

Oxaliplatin H2O Solubility

No information avaliable

Oxaliplatin State

Solid

Oxaliplatin LogP

No information avaliable

Oxaliplatin Dosage Forms

No information avaliable

Oxaliplatin Indication

For the treatment of malignant neoplasm of colon, rectum, and ovary

Oxaliplatin Pharmacology

Oxaliplatin selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of Oxaliplatin-induced cross-linking. At high concentrations of the drug, cellular RNA and protein synthesis are also suppressed.

Oxaliplatin Absorption

No information avaliable

Oxaliplatin side effects and Toxicity

No information avaliable

Oxaliplatin Patient Information

Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.

Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.

Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.

Oxaliplatin Organisms Affected

Humans and other mammals